Current Trends in Gastrointestinal Malignancies

Venue: The Westin Pasadena

Location: Pasadena, CA., United States

Event Date/Time: May 01, 2010 End Date/Time: May 01, 2010
Registration Date: Apr 30, 2010
Early Registration Date: Apr 30, 2010
Report as Spam

Description

The Current Trends in Gastrointestinal Malignancies regional symposia are a series of 1-day seminars designed to update practicing medical oncologists, gastroenterologists, nurses, and other clinicians on the broad advances that have been made in the prevention, early diagnosis, and therapy of gastrointestinal malignancies in recent years. This series will provide cutting-edge updates on the biology, diagnosis, and multidisciplinary management of cancers of the gastrointestinal tract, including data from recent international meetings. Controversies in the clinical management of these malignancies will be outlined, and changes in treatment paradigms will be reviewed. Investigational agents for gastrointestinal malignancies and relevant ongoing clinical trials will also be discussed in-depth. This interactive meeting will include both didactic sessions and case-based discussions with audience participation and responses from leading faculty that will cover all aspects of research and patient management.

This educational program is directed toward medical, surgical, and radiation oncologists and gastroenterologists interested in the treatment of patients with gastrointestinal malignancies. Fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of gastrointestinal malignancies are also invited to attend.

Venue

191 North Los Robles Ave.
Pasadena
CA.
United States
MORE INFO ON THIS VENUE

Additional Information

At the conclusion of this symposium, you should be able to: Utilize current knowledge of the clinical value of biomarkers in the selection of systemic therapy options for metastatic colorectal cancer Select the optimal adjuvant therapy for patients with early-stage colorectal cancer based on current clinical trial results Debate the use of oral vs. intravenous fluoropyrimidines, sequential vs. combination chemotherapy, and continuous vs. intermittent chemotherapy for metastatic colorectal cancer Describe agents targeting novel pathways, such as the IGF-1R, VEGFR, c-Met, Src kinase, mTOR, angiopoietin, and apoptosis pathways, in development for the treatment of colorectal cancer Identify the patients with localized rectal cancer most likely to benefit from radiation therapy Incorporate current clinical trial data on neoadjuvant therapy for gastroesophageal junction adenocarcinoma into decision making in clinical practice Assess the value of biomarker evaluation in the management of patients with advanced gastric cancer Compare and contrast patient outcomes from clinical trials assessing systemic chemotherapy and radiation as adjuvant therapy for resectable pancreatic cancer Evaluate the role of chemoembolization in combination with targeted therapy in the treatment of unresectable hepatocellular carcinoma